TOKYO -- In the global race to develop COVID-19 vaccines, Japan has been conspicuous by its absence. But if the world's third-largest economy is to find standard-bearers in the push for homegrown vaccines, Shionogi, a maker of drugs for infectious diseases, and its media-savvy CEO, Isao Teshirogi, might be prime candidates.
Pharmaceuticals
Shionogi leads Japan's push for homegrown vaccines
Osaka-based company bets on COVID treatments for further growth
A COVID-19 vaccine from Shionogi, led by CEO Isao Teshirogi, would fit the national strategy for domestic vaccine development and could suit the demand for ones with fewer side effects. (Source photos by screenshot from Shionogi's website, courtesy of Shionogi and Atsushi Ooka)
Read Next
Latest on Pharmaceuticals
